Fischer Medical Ventures Outlines Multi-Segment Growth Strategy, Expansion, and Capital Infusion
Fischer Medical Ventures Ltd · Others (Uncategorized) · 16 Sept 2026, 9:17 pm
Fischer Medical Ventures Outlines Multi-Segment Growth Strategy, Expansion, and Capital Infusion Fischer Medical Ventures operates across Radiology, Preventive Healthcare, and Wellness Solutions. In Radiology, key offerings include low-field and helium-free MRIs, CTs, and an order worth ₹9.29 crore for 65 X-ray units from Tamil Nadu. The firm is expanding internationally with TB initiatives in Indonesia and MRI installations in the Philippines, plus plans for 20 rehabilitation centers in Malaysia. In Aug'26, promoters infused approximately ₹59.67 crore via warrants and preferential allotment, increasing their stake from 62.15% to 63.08%. Collaborations include Vecura for AI-driven molecular research.
Original exchange filing (PDF)
More announcements from Fischer Medical Ventures Ltd
- Financial results for the quarter and half year ended 30th Sept 2026 · 15 Nov 2026
- Outcome of Board Meeting held on 14th Nov 2026 for approval of Q2 financials · 15 Nov 2026
- Fischer Medical Ventures Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 15 Nov 2026
- The Monitoring Agency Report for the quarter ended 30 September 2026 is enclosed. · 14 Nov 2026
- Fischer Medical Ventures Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. · 14 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 · 14 Nov 2026
- Fischer Medical Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve the unaudited standalone .... · 14 Nov 2026
- Appointment of Mr Chan Sing En as an Independent Director of FMV Global Innovations Pte.Ltd, Singapore, a Material Wholly Owned Subsidiary Company · 27 Oct 2026
